Generic drugs prescription behavior: A pilot study on Tunisian doctors

References

• Dubois P, Tunçel T. Identifying the effects of scientific information and recommendations on physicians’ prescribing behavior. J Health Econ. 2021;78:102461.
   PubMed Web of Science ®Google Scholar
• Kobayashi E, Karigome H, Sakurada T, et al. Patients’ attitudes towards generic drug substitution in Japan. Health Policy. 2011;99(1):60–65.
   PubMed Web of Science ®Google Scholar
• Hohmann NS, Garza KB, Surry D, et al. Healthcare provider opinions about a generic drug educational newsletter. Res Soc Admin Pharm. 2020;16(9):1228–1236.
   PubMed Web of Science ®Google Scholar
• Al Hussaini M, Alsaffar N, Abdulraheem A. Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: highlighting the role of pharmacist. Bull Fac Pharm Cairo Univ. 2018;56(1):109–114.
   Google Scholar
• Dunne S, Shannon B, Dunne C, et al. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol. 2013;14(1):1.
   PubMed Web of Science ®Google Scholar
• Hamann J, Mendel R, Kissling W, et al. Psychiatrists’ decision making between branded and generic drugs. Eur Neuropsychopharmacol. 2013;23(7):686–690.
   PubMed Web of Science ®Google Scholar
• Khazzaka M. Pharmaceutical marketing strategies’ influence on physicians’ prescribing pattern in Lebanon: ethics, gifts, and samples. BMC Health Serv Res. 2019;19(1):1–11.
   PubMedGoogle Scholar
• Ferreira VL, da Veiga CRP, Kudlawicz-Franco C, et al. Generic drugs in times of economic crisis: are there changes in consumer purchase intention? J Retail Consum Serv. 2017;37:1–7.
   Web of Science ®Google Scholar
• Hassali MA, Alrasheedy AA, McLachlan A, et al. The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J. 2014;22(6):491–503.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Calvillo JA. Psychsocial factors associated with the prescription of generic drugs. Health Policy. 2011.
   Google Scholar
• Skipper N, Vejlin R. Determinants of generic vs. brand drug choice: evidence from population-wide Danish data. Soc Sci Med. 2015;130:204–215.
   PubMed Web of Science ®Google Scholar
• Ellithorpe ME. Parents' behaviors and experience associated with vaccination behavior groups for childhood vaccine hesitancy. Matern Child Health J. 2022:1–9.
   Web of Science ®Google Scholar
• Aree-Ue S, Pellamul M. Osteoporosis knowledge, health beliefs, and preventive behavior: a comparison between younger and older women living in a rural area. Health Care Women Int. 2013;34:1051–1066.
   PubMed Web of Science ®Google Scholar
• Lee KM, Hunger JM, Tomiyama AJ. Weight stigma and health behaviors: evidence from the Eating in America Study. Int J Obes (Lond). 2021;45:1499–1509.
   PubMed Web of Science ®Google Scholar
• Kim N, Lee S, Lee C K, et al. Predicting preventive travel behaviors under the COVID-19 pandemic through an integration of Health Belief Model and Value-Belief-Norm. Tour Manag Perspect. 2022;43:100981.
   PubMed Web of Science ®Google Scholar
• Bakhshi F, Mitchell R, Nasrabadi AN, et al. Behavioural changes in medication safety: consequent to an action research intervention. J Nurs Manag. 2021;29(2):152–164.
   PubMed Web of Science ®Google Scholar
• Babatola AO, Fadare JO, Olatunya OS, et al. Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs. Expert Rev Anti Infect Ther. 2021;19(4):537–546.
   PubMed Web of Science ®Google Scholar
• Nikolopoulos K, Buxton S, Khammash M, et al. Forecasting branded and generic pharmaceuticals. Int J Forecast. 2016;32(2):344–357.
   Web of Science ®Google Scholar
• Qayyum A. Bioequivalence studies. In: Readings in advanced pharmacokinetics-theory, methods and applications. IntechOpen; 2012. p. 1.
   Google Scholar
• Davit B, Braddy AC, Conner DP. International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences. AAPS J. 2013;15(4):974–990.
   PubMed Web of Science ®Google Scholar
• Chaudhary RK, Philip MJ, Santhosh A, et al. Health economics and effectiveness analysis of generic anti-diabetic medication from Jan Aushadhi: an ambispective study in community pharmacy. Diabetes Metab Syndr: Clin Res Rev. 2021;15(6):102303–102303.
   PubMed Web of Science ®Google Scholar
• Ghani W, Jambulingam T, Sharma R. Internet marketing in healthcare: The case of generic drugs and the contagion effect. Int J Healthc Manag. 2019.
   PubMed Web of Science ®Google Scholar
• Kaló Z, Holtorf AP, Alfonso-Cristancho R, et al. Need for multicriteria evaluation of generic drug policies. Value Health. 2015;18(2):346–351.
   PubMed Web of Science ®Google Scholar
• Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25(11):2875–2890.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Verma S, Halappanavar M. Measuring the effectiveness of benzodiazepine prescriptions control in community setting using prescription drug monitoring program (PDMP). Community Ment Health J. 2021;57(5):920–925.
   PubMed Web of Science ®Google Scholar
• Holden RJ, Srinivas P, Campbell NL. Understanding older adults' medication decision making and behavior. Res Social Adm Pharm. 2019;15:53–60.
   PubMed Web of Science ®Google Scholar
• Prosser H, Walley T. A qualitative study of GPs’ and PCO stakeholders’ views on the importance and influence of cost on prescribing. Soc Sci Med. 2005;60(6):1335–1346.
   PubMed Web of Science ®Google Scholar
• Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1–47.
   PubMedGoogle Scholar
• Ataei P, Gholamrezai S, Movahedi R, et al. An analysis of farmers’ intention to use green pesticides: the application of the extended theory of planned behavior and health belief model. J Rural Stud. 2021;81:374–384.
   Web of Science ®Google Scholar
• Bandura A. Health promotion from the perspective of social cognitive theory. Psychol Health. 1998;13(4):623–649.
   Web of Science ®Google Scholar
• Fernandez-Lazaro CI, Adams DP, Fernandez-Lazaro D, et al. Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions. Res Social Adm Pharm. 2019;15:744–753.
   PubMed Web of Science ®Google Scholar
• Denscombe M. UK health policy and ‘underage’ smokers: the case for smoking cessation services. Health Policy. 2007;80(1):69–76.
   PubMed Web of Science ®Google Scholar
• Wójcik P. Projective techniques in evaluation research. Evaluation at strategic level of governance. 2011: 87.
   Google Scholar
• Romelaer P. Chapitre 4. L’entretien de recherche. In: Méthodes et Recherches. 2005. p. 101–137. No. hal-00160028.
   Google Scholar
• Lichtenstein DR, Ridgway NM, Netemeyer RG. Price perceptions and consumer shopping behavior: a field study. J Mark Res. 1993.
   Web of Science ®Google Scholar
• Bandura A. Social foundations of thought and action. Englewood Cliffs (NJ); 1986. p. 23–28.
   Google Scholar
• Riaz H, Krasuski RA. Should physicians be encouraged to use generic names and to prescribe generic drugs? Am J Cardiol. 2016;117(11):1851–1852.
   PubMed Web of Science ®Google Scholar
• Tracy SJ. A toxic and mythical combination of a deductive writing logic for inductive qualitative research. Qual Comms Res. 2012;1:109–141.
   Google Scholar
• Worthington RP. Ethics and professionalism in a changing world. Investig Educ Medica. 2015.
   Google Scholar